23.7.2024
17.7.2024
11.7.2024
13
Aug
2024
16
21
Find more news and events
Suomeksi
In English
Metformin is the first-line drug that can lower blood sugar levels in type 2 diabetes patients. One third of patients do not respond to metformin treatment and 5 per cent experience serious side effects.
A new study conducted by researchers at the University of Eastern Finland found that the PLCG2-P522R genetic variant, which protects against Alzheimer’s disease, enhances several key functions of immune cells.
The majority of patients are seizure-free five years after epilepsy surgery, according to a unique European collaborative study.
Many Finns are risk takers when it comes to alcohol. Reaching middle age can be a turning point – or the end of the line.